Sharon Hrynkow's most recent trade in Forward Industries, Inc. was a trade of 12,147 Stock Options (Right to Buy) done . Disclosure was reported to the exchange on June 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Forward Industries, Inc. | Sharon Hrynkow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2025 | 12,147 | 12,147 | - | - | Stock Options (Right to Buy) | |
| Forward Industries, Inc. | Sharon Hrynkow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2024 | 24,010 | 24,010 | - | - | Stock Options (Right to Buy) | |
| Forward Industries, Inc. | Sharon Hrynkow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 41,580 | 41,580 | - | - | Stock Options (Right to Buy) | |
| Forward Industries, Inc. | Sharon Hrynkow | Director | Purchase of securities on an exchange or from another person at price $ 1.13 per share. | 20 Dec 2022 | 5,000 | 10,000 (0%) | 0% | 1.1 | 5,650 | Common Stock |
| Forward Industries, Inc. | Sharon Hrynkow | Director | Purchase of securities on an exchange or from another person at price $ 1.16 per share. | 20 Dec 2022 | 4,855 | 14,855 (0%) | 0% | 1.2 | 5,632 | Common Stock |
| Forward Industries, Inc. | Sharon Hrynkow | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2022 | 31,095 | 31,095 | - | - | Stock Options (Right to Buy) | |
| Cyclo Therapeutics Inc - O... | Sharon Hrynkow | Chief Scientific Officer | Purchase of securities on an exchange or from another person at price $ 4.98 per share. | 02 Dec 2021 | 1,000 | 19,350 | - | 5.0 | 4,980 | Common Stock |
| Cyclo Therapeutics Inc - O... | Sharon Hrynkow | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Aug 2021 | 23,800 | 23,800 | - | - | Stock Option (Right to buy) | |
| Cyclo Therapeutics Inc - O... | Sharon Hrynkow | Chief Scientific Officer | Purchase of securities on an exchange or from another person at price $ 7.46 per share. | 29 Mar 2021 | 1,000 | 18,350 | - | 7.5 | 7,460 | Common Stock |
| Cyclo Therapeutics Inc - O... | Sharon Hrynkow | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2021 | 10,000 | 17,350 | - | 0 | Common Stock | |
| Cyclo Therapeutics Inc - O... | Sharon Hrynkow | Chief Scientific Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 11 Dec 2020 | 1,000 | 1,000 | - | - | Warrant to Purchase Common Stock | |
| Cyclo Therapeutics Inc - O... | Sharon Hrynkow | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Dec 2020 | 1,000 | 7,350 | - | - | Common Stock |